Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Christos V. Rizos & Moses S. Elisaf. (2016) Telmisartan: a multifaceted antihypertension drug. Current Medical Research and Opinion 32:8, pages 1397-1398.
Read now
Read now
Manfredi Rizzo, Angelo Avogaro, Giuseppe Montalto & Ali A Rizvi. (2013) Non-glycemic effects of pioglitazone and incretin-based therapies. Expert Opinion on Therapeutic Targets 17:7, pages 739-742.
Read now
Read now
Sana Khan, Saba Khan, Mohammed Imran, Krishna Kolappa Pillai, Mohd Akhtar & Abul Kalam Najmi. (2013) Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus – targeting thrombogenesis. Expert Opinion on Therapeutic Targets 17:6, pages 627-639.
Read now
Read now
Niki Katsiki & Moses Elisaf. (2011) Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease. Current Medical Research and Opinion 27:8, pages 1669-1672.
Read now
Read now
Nikolaos Papanas, Niki Katsiki, Apostolos I Hatzitolios & Efstratios Maltezos. (2011) Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 12:10, pages 1457-1461.
Read now
Read now
Aris P Agouridis, Theodosios D Filippatos, Vasilios Tsimihodimos & Moses S Elisaf. (2011) Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism. Expert Review of Cardiovascular Therapy 9:3, pages 355-366.
Read now
Read now
Niki Katsiki, Nikolaos Papanas & Dimitri P Mikhailidis. (2010) Dapagliflozin: more than just another oral glucose-lowering agent?. Expert Opinion on Investigational Drugs 19:12, pages 1581-1589.
Read now
Read now
Dorte Glintborg & Marianne Andersen. (2010) Thiazolinedione treatment in PCOS – an update. Gynecological Endocrinology 26:11, pages 791-803.
Read now
Read now
Annie A. Mavian, Stephan Miller & Robert R. Henry. (2010) Managing Type 2 Diabetes: Balancing HbA1c and Body Weight. Postgraduate Medicine 122:3, pages 106-117.
Read now
Read now
Evan Rosen, Jun Eguchi & Zhao Xu. (2009) Transcriptional targets in adipocyte biology. Expert Opinion on Therapeutic Targets 13:8, pages 975-986.
Read now
Read now
CV Rizos, Moses Elisaf, DP Mikhailidis & EN Liberopoulos. (2009) How safe is the use of thiazolidinediones in clinical practice?. Expert Opinion on Drug Safety 8:1, pages 15-32.
Read now
Read now
M Florentin, EN Liberopoulos, DP Mikhailidis & Elisaf MS. (2008) Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 9:10, pages 1705-1720.
Read now
Read now
Articles from other publishers (41)
Francesca Mancinetti, Dionysios Xenos, Michelantonio De Fano, Alessio Mazzieri, Francesca Porcellati, Virginia Boccardi & Patrizia Mecocci. (2023) Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways. Ageing Research Reviews 90, pages 102018.
Crossref
Crossref
Rana Hussein Kutaif, Mustafa G. Alabbassi, Weqar Akram Hussein, Zainab Faleh Ali & Shatha Khayun Jassim. (2022) Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.. Al Mustansiriyah Journal of Pharmaceutical Sciences 21:1, pages 26-33.
Crossref
Crossref
Rick Cousins. 2022.
1
91
.
Jiahao Zhu, Lingling Sun, Jing Yang, Jiayao Fan, Lap Ah Tse & Yingjun Li. (2021) Genetic Predisposition to Type 2 Diabetes and Insulin Levels Is Positively Associated With Serum Urate Levels. The Journal of Clinical Endocrinology & Metabolism 106:7, pages e2547-e2556.
Crossref
Crossref
Niki Katsiki, George D. Dimitriadis & Dimitri P. Mikhailidis. (2021) Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease. Current Pharmaceutical Design 27:16, pages 1941-1951.
Crossref
Crossref
Carlos M. González-Casimiro, Beatriz Merino, Elena Casanueva-Álvarez, Tamara Postigo-Casado, Patricia Cámara-Torres, Cristina M. Fernández-Díaz, Malcolm A. Leissring, Irene Cózar-Castellano & Germán Perdomo. (2021) Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme. Biomedicines 9:1, pages 86.
Crossref
Crossref
Mattia Albiero, Benedetta Maria Bonora & Gian Paolo Fadini. (2020) Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps. Current Opinion in Pharmacology 55, pages 151-156.
Crossref
Crossref
Antonino Di Pino & Ralph A DeFronzo. (2019) Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocrine Reviews 40:6, pages 1447-1467.
Crossref
Crossref
Yaser Khajebishak, Laleh Payahoo, Mohammadreza Alivand & Beitollah Alipour. (2018) Punicic acid: A potential compound of pomegranate seed oil in Type 2 diabetes mellitus management. Journal of Cellular Physiology 234:3, pages 2112-2120.
Crossref
Crossref
Jaehyun Bae, Gyuri Kim, Yong-Ho Lee, Byung-Wan Lee, Eun Seok Kang & Bong-Soo Cha. (2018) Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis. Diabetes Therapy 10:1, pages 149-158.
Crossref
Crossref
Fabiola Paciello, Anna Rita Fetoni, Rolando Rolesi, Matthew B. Wright, Claudio Grassi, Diana Troiani & Gaetano Paludetti. (2018) Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure. Frontiers in Pharmacology 9.
Crossref
Crossref
Panagiotis Anagnostis, Pavlos Siolos, Konstantinos Christou, Nifon K. Gkekas, Nikoletta Kosmidou, Vasilios G. Athyros & Asterios Karagiannis. (2018) The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data. Hormones 17:1, pages 83-95.
Crossref
Crossref
A Surendiran, V Saranya & N Anusha. (2018) Pharmacogenomics of Type 2 Diabetes Mellitus. SBV Journal of Basic, Clinical and Applied Health Science 1:A1, pages 6-19.
Crossref
Crossref
Einat Almon, Tawfik Khoury, Ariel Drori, Svetlana Gingis-Velitski, Sari Alon, Raul Chertkoff, Mordechai Mushkat, Yoseph Shaaltiel & Yaron Ilan. (2017) An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. Journal of Immunological Methods 446, pages 21-29.
Crossref
Crossref
Ashok Kumar Singh, Avinash C. Tripathi, Aseem Tewari, Viney Chawla & Shailendra K. Saraf. (2017) Design and microwave facilitated green synthesis of 2-[4-(3-carboxymethyl, methoxy carbonylmethyl-2,4-dioxo and 4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-phenoxy]-2 and 3-methyl propionic acid ethyl ester derivatives: a novel structural class of antidyslipidemic agents. Medicinal Chemistry Research 26:7, pages 1535-1549.
Crossref
Crossref
Niki Katsiki & Dimitri P. Mikhailidis. (2017) Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684–1692. Diabetes Care 40:4, pages e46-e46.
Crossref
Crossref
Christos V. Rizos, Anastazia Kei & Moses S. Elisaf. (2016) The current role of thiazolidinediones in diabetes management. Archives of Toxicology 90:8, pages 1861-1881.
Crossref
Crossref
Fang Ding, Jiamin Qiu, Qingqing Li, Jiwei Hu, Chenling Song, Chunchun Han, Hua He & Jiwen Wang. (2015) Effects of rosiglitazone on proliferation and differentiation of duck preadipocytes. In Vitro Cellular & Developmental Biology - Animal 52:2, pages 174-181.
Crossref
Crossref
Christos V. Rizos, Evangelos N. Liberopoulos, Kostas Tellis, James J. DiNicolantonio, Alexandros D. Tselepis & Moses S. Elisaf. (2013) Combining Rosuvastatin With Angiotensin-Receptor Blockers of Different PPARγ-Activating Capacity. Angiology 66:1, pages 36-42.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Devaki R. Nair. (2014) The effects of antiepileptic drugs on vascular risk factors: A narrative review. Seizure 23:9, pages 677-684.
Crossref
Crossref
Han-Mo Yang, Baek-Kyung Kim, Ju-Young Kim, Yoo-Wook Kwon, Sooryeonhwa Jin, Joo-Eun Lee, Hyun-Jai Cho, Hae-Young Lee, Hyun-Jae Kang, Byung-Hee Oh, Young-Bae Park & Hyo-Soo Kim. (2013) PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury. Experimental & Molecular Medicine 45:11, pages e65-e65.
Crossref
Crossref
Niki Katsiki, Asterios Karagiannis, Vasilios G. Athyros & Dimitri P. Mikhailidis. (2013) Hyperuricaemia. Journal of Cardiovascular Medicine 14:6, pages 397-402.
Crossref
Crossref
Christos V. Rizos & Moses S. Elisaf. (2013) Metformin and cancer. European Journal of Pharmacology 705:1-3, pages 96-108.
Crossref
Crossref
Anna Köttgen, Eva Albrecht, Alexander Teumer, Veronique Vitart, Jan Krumsiek, Claudia Hundertmark, Giorgio Pistis, Daniela Ruggiero, Conall M O'Seaghdha, Toomas Haller, Qiong Yang, Toshiko Tanaka, Andrew D Johnson, Zoltán Kutalik, Albert V Smith, Julia Shi, Maksim Struchalin, Rita P S Middelberg, Morris J Brown, Angelo L Gaffo, Nicola Pirastu, Guo Li, Caroline Hayward, Tatijana Zemunik, Jennifer Huffman, Loic Yengo, Jing Hua Zhao, Ayse Demirkan, Mary F Feitosa, Xuan Liu, Giovanni Malerba, Lorna M Lopez, Pim van der Harst, Xinzhong Li, Marcus E Kleber, Andrew A Hicks, Ilja M Nolte, Asa Johansson, Federico Murgia, Sarah H Wild, Stephan J L Bakker, John F Peden, Abbas Dehghan, Maristella Steri, Albert Tenesa, Vasiliki Lagou, Perttu Salo, Massimo Mangino, Lynda M Rose, Terho Lehtimäki, Owen M Woodward, Yukinori Okada, Adrienne Tin, Christian Müller, Christopher Oldmeadow, Margus Putku, Darina Czamara, Peter Kraft, Laura Frogheri, Gian Andri Thun, Anne Grotevendt, Gauti Kjartan Gislason, Tamara B Harris, Lenore J Launer, Patrick McArdle, Alan R Shuldiner, Eric Boerwinkle, Josef Coresh, Helena Schmidt, Michael Schallert, Nicholas G Martin, Grant W Montgomery, Michiaki Kubo, Yusuke Nakamura, Toshihiro Tanaka, Patricia B Munroe, Nilesh J Samani, David R JacobsJrJr, Kiang Liu, Pio D'Adamo, Sheila Ulivi, Jerome I Rotter, Bruce M Psaty, Peter Vollenweider, Gerard Waeber, Susan Campbell, Olivier Devuyst, Pau Navarro, Ivana Kolcic, Nicholas Hastie, Beverley Balkau, Philippe Froguel, Tõnu Esko, Andres Salumets, Kay Tee Khaw, Claudia Langenberg, Nicholas J Wareham, Aaron Isaacs, Aldi Kraja, Qunyuan Zhang, Philipp S Wild, Rodney J Scott, Elizabeth G Holliday, Elin Org, Margus Viigimaa, Stefania Bandinelli, Jeffrey E Metter, Antonio Lupo, Elisabetta Trabetti, Rossella Sorice, Angela Döring, Eva Lattka, Konstantin Strauch, Fabian Theis, Melanie Waldenberger, H-Erich Wichmann, Gail Davies, Alan J Gow, Marcel Bruinenberg, Ronald P Stolk, Jaspal S Kooner, Weihua Zhang, Bernhard R Winkelmann, Bernhard O Boehm, Susanne Lucae, Brenda W Penninx, Johannes H Smit, Gary Curhan, Poorva Mudgal, Robert M Plenge, Laura Portas, Ivana Persico, Mirna Kirin, James F Wilson, Irene Mateo Leach, Wiek H van Gilst, Anuj Goel, Halit Ongen, Albert Hofman, Fernando Rivadeneira, Andre G Uitterlinden, Medea Imboden, Arnold von Eckardstein, Francesco Cucca, Ramaiah Nagaraja, Maria Grazia Piras, Matthias Nauck, Claudia Schurmann, Kathrin Budde, Florian Ernst, Susan M Farrington, Evropi Theodoratou, Inga Prokopenko, Michael Stumvoll, Antti Jula, Markus Perola, Veikko Salomaa, So-Youn Shin, Tim D Spector, Cinzia Sala, Paul M Ridker, Mika Kähönen, Jorma Viikari, Christian Hengstenberg, Christopher P Nelson, James F Meschia, Michael A Nalls, Pankaj Sharma, Andrew B Singleton, Naoyuki Kamatani, Tanja Zeller, Michel Burnier, John Attia, Maris Laan, Norman Klopp, Hans L Hillege, Stefan Kloiber, Hyon Choi, Mario Pirastu, Silvia Tore, Nicole M Probst-Hensch, Henry Völzke, Vilmundur Gudnason, Afshin Parsa, Reinhold Schmidt, John B Whitfield, Myriam Fornage, Paolo Gasparini, David S Siscovick, Ozren Polašek, Harry Campbell, Igor Rudan, Nabila Bouatia-Naji, Andres Metspalu, Ruth J F Loos, Cornelia M van Duijn, Ingrid B Borecki, Luigi Ferrucci, Giovanni Gambaro, Ian J Deary, Bruce H R Wolffenbuttel, John C Chambers, Winfried März, Peter P Pramstaller, Harold Snieder, Ulf Gyllensten, Alan F Wright, Gerjan Navis, Hugh Watkins, Jacqueline C M Witteman, Serena Sanna, Sabine Schipf, Malcolm G Dunlop, Anke Tönjes, Samuli Ripatti, Nicole Soranzo, Daniela Toniolo, Daniel I Chasman, Olli Raitakari, W H Linda Kao, Marina Ciullo, Caroline S Fox, Mark Caulfield, Murielle Bochud & Christian Gieger. (2012) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nature Genetics 45:2, pages 145-154.
Crossref
Crossref
Letizia Giampietro, Alessandra D’Angelo, Antonella Giancristofaro, Alessandra Ammazzalorso, Barbara De Filippis, Marialuigia Fantacuzzi, Pasquale Linciano, Cristina Maccallini & Rosa Amoroso. (2012) Synthesis and structure–activity relationships of fibrate-based analogues inside PPARs. Bioorganic & Medicinal Chemistry Letters 22:24, pages 7662-7666.
Crossref
Crossref
Pantelis A. Sarafidis, Panagiotis I. Georgianos & Anastasios N. Lasaridis. (2011) PPAR-γ Agonism for Cardiovascular and Renal Protection. Cardiovascular Therapeutics 29:6, pages 377-384.
Crossref
Crossref
Niki Katsiki, John G. Yovos, Anna Gotzamani-Psarrakou & Dimitrios T. Karamitsos. (2011) Adipokines and Vascular Risk in Type 2 Diabetes Mellitus. Angiology 62:8, pages 601-604.
Crossref
Crossref
Lili Zhang, Ling Li, Mengliu Yang, Hua Liu & Gangyi Yang. (2011) Elevated circulating vaspin levels were decreased by rosiglitazone therapy in T2DM patients with poor glycemic control on metformin alone. Cytokine 56:2, pages 399-402.
Crossref
Crossref
Sanja S. Soskić, Branislava D. Dobutović, Emina M. Sudar, Milan M. Obradović, Dragana M. Nikolić, Božidarka L. Zarić, Srđan Đ. Stojanović, Edita J. Stokić, Dimitri P. Mikhailidis & Esma R. Isenović. (2011) Peroxisome Proliferator-Activated Receptors and Atherosclerosis. Angiology 62:7, pages 523-534.
Crossref
Crossref
Christos V. RizosEvangelos N. LiberopoulosConstantinos C. TellisMatilda FlorentinMoses S. ElisafAlexandros D. Tselepis. (2011)
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-γ Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A
2
. Metabolic Syndrome and Related Disorders 9:3, pages 217-223.
Crossref
Crossref
Ajit Vikram, Gopabandhu Jena & Poduri Ramarao. (2010) Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia. British Journal of Pharmacology 161:8, pages 1708-1721.
Crossref
Crossref
Yongqing YangGongshe Yang. (2010) Rosiglitazone regulates IL-6-stimulated lipolysis in porcine adipocytes. Biochemistry and Cell Biology 88:5, pages 853-860.
Crossref
Crossref
Prabal K Chatterjee. (2010) Hepatic inflammation and insulin resistance in pre‐diabetes – further evidence for the beneficial actions of PPAR‐γ agonists and a role for SOCS‐3 modulation. British Journal of Pharmacology 160:8, pages 1889-1891.
Crossref
Crossref
E. Erdmann & R. Wilcox. (2009) Pioglitazone and mechanisms of CV protection. QJM 103:4, pages 213-228.
Crossref
Crossref
R. Ferrer-Lorente, C. Cabot, J. A. Fernández-López & M. Alemany. (2010) Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats. Naunyn-Schmiedeberg's Archives of Pharmacology 381:4, pages 339-348.
Crossref
Crossref
Nikolaos P.E. Kadoglou, Hercules Tsanikidis, Alkistis Kapelouzou, Ioannis Vrabas, Ioulia Vitta, Panayotis E. Karayannacos, Christos D. Liapis & Nikolaos Sailer. (2010) Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Metabolism 59:3, pages 373-379.
Crossref
Crossref
J. E. Toblli, M. G. Ferrini, G. Cao, D. Vernet, M. Angerosa & N. F. Gonzalez-Cadavid. (2009) Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrology Dialysis Transplantation 24:8, pages 2384-2391.
Crossref
Crossref
Rajani Kaimal, Xiulong Song, Bingfang Yan, Roberta King & Ruitang Deng. (2009) Differential Modulation of Farnesoid X Receptor Signaling Pathway by the Thiazolidinediones. Journal of Pharmacology and Experimental Therapeutics 330:1, pages 125-134.
Crossref
Crossref
Elmar Aigner, Nora Bachofner, Kerstin Klein, Christian De Geyter, Florian Hohla, Wolfgang Patsch & Christian Datz. (2009) Retinol-Binding Protein 4 in Polycystic Ovary Syndrome—Association with Steroid Hormones and Response to Pioglitazone Treatment. The Journal of Clinical Endocrinology & Metabolism 94:4, pages 1229-1235.
Crossref
Crossref
Liliana Monica Bivol, Michael Hultström, Oddrun A. Gudbrandsen, Rolf K. Berge & Bjarne M. Iversen. (2008) Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 295:6, pages R1866-R1873.
Crossref
Crossref
Wook Kim & Josephine M. Egan. (2008) The Role of Incretins in Glucose Homeostasis and Diabetes Treatment. Pharmacological Reviews 60:4, pages 470-512.
Crossref
Crossref